Results 161 to 170 of about 79,932 (302)
International Journal of Gynecology &Obstetrics, EarlyView.
Pedro Junqueira Fleury Silva +12 more
wiley +1 more source
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a common comorbidity of pediatric obesity that predisposes patients to hepatocellular adenomas (HCAs). HCAs however are nonspecific to MASLD and warrant further evaluation. We present a case of a 16‐year‐old male with severe obesity, and persistently elevated liver enzymes ...
Carolena Trocchia +3 more
wiley +1 more source
Abstract Proline and glutamate‐rich protein with a coiled coil domain 1 (PERCC1)‐associated enteropathy is a rare monogenic congenital diarrhea due to defective enteroendocrine cells (EECs). We describe a 6‐year‐old female with intestinal failure since birth.
Teresa Di Chio +9 more
wiley +1 more source
Performance of lupus classification criteria in monogenic lupus: a national multicentre cohort study. [PDF]
Akay N +43 more
europepmc +1 more source
Abstract We report a patient with Hoyeraal–Hreidarsson syndrome (HHS), a telomere biology disorder, who developed severe chronic enterocolitis with inflammatory bowel disease‐like features. Vedolizumab led to improvement in stool frequency, reduced fecal calprotectin, and clinical remission without infectious complications.
Yasutaka Chiba +6 more
wiley +1 more source
Model Matters: Genetic Architecture and Cardiovascular Physiology in Translational Medicine. [PDF]
Kleinbongard P, Vilahur G.
europepmc +1 more source
ABSTRACT Setmelanotide is a melanocortin‐4 receptor agonist approved for the treatment of rare forms of genetic obesity. Through off‐target activation of the melanocortin‐1 receptor, it may induce cutaneous pigmentation changes; however, data regarding its effects on melanocytic nevi remain limited.
Martina Cavicchi +5 more
wiley +1 more source
Disease associations for rare immune genetic variants require statistical or rule-based support. [PDF]
Gray PE, Tangye SG, Kirk EP.
europepmc +1 more source
Abstract Background Childhood‐onset hyperkinetic movement disorders occur in a range of genetic conditions. Recently, there has been an increase in recognition of hyperkinetic movement disorders, mainly dystonia, chorea and dyskinesia, with monogenic conditions associated with neurodevelopmental delay (NDD) and also with developmental and epileptic ...
Hugo Morales‐Briceño +6 more
wiley +1 more source

